Stocks Clock Fourth...
Health Care: Drugs
AstraZeneca PLC (AZN: NYSE)
$51.56 -0.27 | -0.52%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 51.56 |
| 52 Week High | 52.27 |
| 52 Week Low | 39.72 |
| Avg. Daily Vol. (Mil) | 2.01 |
| Beta (3 year) | 0.55 |
| Share Related Items | |
| Mkt Cap (Mil) | 64,450.00 |
| Shares Out (Mil) | 1,250.00 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 7.40 |
| Annual Dividend | 3.80 |
| Payout Ratio | 62.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.30 |
| LT Debt/ Equity | 0.42 |
| Total Debt / Equity | 0.46 |
| Valuation Ratios | |
| Price Earnings | 11.40 |
| Price/Sales | 2.39 |
| Price/Book | 2.89 |
| Price/Cash Flow | 9.50 |
| Per Share Data | |
| Earnings | 4.51 |
| Sales | 21.61 |
| Book Value | 17.83 |
| Cash Flow | 5.40 |
| Business Summary | |
|---|---|
| AstraZeneca PLC a biopharmaceutical company focusing on six Therapy Areas: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology and Respiratory & Inflammation. It owns and operates R&D, production and marketing facilities worldwide. | |
| General Information | |
| 2 Kingdom Street
London, W2 6BD |
|
| www.astrazeneca.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 51700 | |
| CEO: Pascal Soriot | |
| Short Interest | |
| Current Month (Mil) | 3.27 |
| Previous Month (Mil) | 2.52 |
| Short Interest Ratio (Days) | 1.50 |
| Management Effectiveness | |
| Return on Equity | 18.30 |
| Return on Assets | 7.80 |
| Return on Investments | 12.90 |
| Profitability | |
| Gross Margin | 90.30 |
| EBIT Margin | 30.20 |
| Profit Margin | 15.10 |
Portfolios with AZN
- Portfolio NameUser Type
- UserDC
- ContributorRocket Stocks for the Week ...
- ContributorRocket Stocks for the Week ...
- Contributor7 Big-Pharma Stocks With Un...
- UserCurrent
- Contributor9 High-Yield Stocks to Cons...
- UserGFNN Stockdiagnostics 14
- UserThe Coming M&A boom
- ContributorHighest-Yielding Drug Stocks
- Contributor10 Dividend Stocks Still Pa...
Latest AZN Headlines from TheStreet
- 5 Stocks Dragging In The Health Care Sector 05.06.13 | 01:05 pm
- 4 Buy-Rated Dividend Stocks 05.02.13 | 12:05 pm
- AstraZeneca Stock Hits New 52-Week High (AZN) 04.29.13 | 01:04 pm
- 4 Stocks Improving Performance Of The Health Care Sector 04.26.13 | 01:04 pm
- AstraZeneca PLC (AZN): Today's Featured Drugs Winner 04.23.13 | 05:04 pm
- AstraZeneca Reaches New 52-Week High (AZN) 04.22.13 | 12:04 pm
- 4 Buy-Rated Dividend Stocks 04.19.13 | 11:04 am
- AstraZeneca Stock Hits New 52-Week High (AZN) 04.09.13 | 11:04 am
- Astra, Rigel Arthritis Pill Posts Mixed Trial Results 04.05.13 | 05:04 am
- Cramer's 6 Stocks in 60 Seconds: YELP NAT AZN HBI TXN URBN (Update 1) 04.02.13 | 05:04 pm
Press Releases for AZN
- AstraZeneca To Establish Strategic R&D Center In Gaithersburg, Md; Wilmington Remains North America Commercial Headquarters - Business Wire 03.18.13 | 09:03 am
- AstraZeneca Encourages Atherosclerosis Education Among High Risk Patients During American Heart Month - PR Newswire 02.14.13 | 09:02 am
- AstraZeneca Recognized As A Top Company For Female Executives - Business Wire 02.05.13 | 12:02 pm
- AstraZeneca HealthCare Foundation: Connections For Cardiovascular HealthSM Accepting Grant Applications - Business Wire 01.09.13 | 09:01 am
- BRILINTA (Ticagrelor) Receives Additional Class I Recommendation In Updated ACCF/AHA Guidelines For The Management Of STEMI Patients - Business Wire 12.17.12 | 03:12 pm
- CRESTOR® US Patent Upheld By Court Of Appeals For The Federal Circuit - Business Wire 12.14.12 | 01:12 pm
- AstraZeneca Updates US Label For FASLODEX® (fulvestrant) Injection - Business Wire 12.05.12 | 11:12 am
- Kaplan-Meier Estimates (Graphic: AstraZeneca) - Business Wire 12.05.12 | 08:12 am
- AstraZeneca To Present Key New Data For Hormone Receptor-Positive Metastatic Breast Cancer At The 35th CTRC-AACR Annual San Antonio Breast Cancer Symposium - Business Wire 12.04.12 | 02:12 pm
- AstraZeneca Makes Major Commitment To Help Patients With Acute Coronary Syndrome Have BRILINTA (ticagrelor) Available In Their Local Communities - Business Wire 12.04.12 | 09:12 am
Partner Headlines for AZN
- Medicines Co. Earnings Top Views; New Drugs Await - Investor's Business Daily 04.24.13 | 04:04 pm
- Astrazeneca Earnings Preview: Can This Streak Continue? - Wall St. Cheat Sheet 04.23.13 | 02:04 am
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- European Stocks Weaken on Downbeat U.S. Jobs Data, North Korean Worries - NASDAQ 04.05.13 | 04:04 pm
- Will AstraZeneca’s Patent Setback Put Off These Top Institutional Shareholders? - Wall St. Cheat Sheet 04.02.13 | 12:04 pm
- Analysts: SanDisk Will Beat Estimates and 4 New Opinions Investors Must Take Note Of - Wall St. Cheat Sheet 04.02.13 | 11:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind - Seeking Alpha 03.25.13 | 09:03 am
- Top 9 March Healthcare Dogs Mark 3.4% To 28.7% Gains - Seeking Alpha 03.23.13 | 04:03 am
- Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 13, 2013 - NASDAQ 02.11.13 | 02:02 pm
